Latest News

Compound reverses symptoms of Alzheimer's disease in mice

Research in an animal model supports the potential therapeutic value of an antisense compound to treat Alzheimer's disease. The molecule also reduced inflammation in the part of the brain responsible for learning and memory. The article is the second mouse study that supports the potential therapeutic value of an antisense compound in treating Alzheimer's disease in humans.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Study on neurogenesis in the olfactory bulb

  • Scientists create mice with a major genetic cause of ALS, frontotemporal dementia

  • Breastfeeding protects against environmental pollution

  • How a schizophrenia risk gene affects the brain

  • New mechanism for Alzheimer's disease confirmed

  • Proteins may slow memory loss in people with Alzheimer's

  • Experts map surgical approaches for auditory brainstem implantation

  • Obese teens' brains unusually susceptible to food commercials, study finds

  • Memories influence choice of food

  • fMRI: New window into the brain

  •